European Archives - Page 1002 of 1137 - European Medical Journal

EMJ

Protein Successfully Predicts Recurrence of Liver Cancer

INVESTIGATIONS of p62 have highlighted the protein as a key factor in cancer recurrence and has been associated with reduced rates of survival in liver…

EMJ

Restricted Calorie Intake Reduces Fat Content of Liver

GROWING rates of obesity have raised concerns regarding the resulting metabolic diseases caused by overeating, such as Type 2 diabetes and liver disease…

EMJ Respiratory 4 [Suppl 11] 2016

El primer congreso de WAidid celebrado en Milán reunió a investigadores y médicos del amplio campo de las enfermedades infecciosas y la inmunología.

Inmunomodulación En Caso De Infecciones Recurrentes De Las vías Respiratorias: Nuevos Conocimientos Y Perspectivas

El primer congreso de WAidid celebrado en Milán reunió a investigadores y médicos del amplio campo de las enfermedades infecciosas y la inmunología Este…

EMJ Respiratory 4 [Suppl 10] 2016

Prof Roth and Prof Esposito presented a symposium on the use of immunomodulation for prophylaxis against recurrent respiratory tract infections…

Immunomodulation for Recurrent Respiratory Tract Infections: New Insights and Perspectives

The 1st biennial WAidid Congress held in Milan, Italy, brought together academics and clinicians from the broad field of infectious diseases and immunology.

IBD Drug Availability Putting Children at Risk of Lifelong Health Complications

June 21, 2016 – To halt the health risks for children and improve outcomes in the future, IBD experts across Europe are calling for an urgent increase in…

Richard Wolf Presents Its Profile at the 24th International Congress of the E.A.E.S in Amsterdam

June 16, 2016 – Particularly in contemporary medicine, the importance of efficient processes is steadily increasing on account of the rising pressure…

iVascular Completes Recruitment of Patients for Its ANCHOR Clinical Trial of the Sirolimus Eluting Stent ANGIOLITE

May 19, 2016 – Coordinated by PI Dr. Josep Rodés-Cabau from Quebec Heart and Lung Institute, the objective of ANCHOR clinical trial is to perform a…

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

May 16, 2016 – LUMINOR 18, which is 0.018 Guide Wire compatible, is added to the existing LUMINOR range (Luminor14 and Luminor35), to offer the only…